Cargando…
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy
Globoid cell leukodystrophy (GLD) is a demyelinating lysosomal storage disease due to the deficiency of the galactocerebrosidase (GALC) enzyme. The favorable outcome of hematopoietic stem and progenitor cell (HSPC)-based approaches in GLD and other similar diseases suggests HSPC gene therapy as a pr...
Autores principales: | Ungari, Silvia, Montepeloso, Annita, Morena, Francesco, Cocchiarella, Fabienne, Recchia, Alessandra, Martino, Sabata, Gentner, Bernhard, Naldini, Luigi, Biffi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605225/ https://www.ncbi.nlm.nih.gov/pubmed/26509184 http://dx.doi.org/10.1038/mtm.2015.38 |
Ejemplares similares
-
Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy
por: Lattanzi, Annalisa, et al.
Publicado: (2014) -
Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy
por: Ricca, Alessandra, et al.
Publicado: (2015) -
Neural Stem Cell Gene Therapy Ameliorates Pathology and Function in a Mouse Model of Globoid Cell Leukodystrophy
por: Neri, Margherita, et al.
Publicado: (2011) -
Globoid Cell Leukodystrophy (Krabbe Disease): An Update
por: Maghazachi, Azzam A
Publicado: (2023) -
Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells
por: Poletti, Valentina, et al.
Publicado: (2023)